Innovative pharmaceutical sector continued to decline in the afternoon, Yuandong Biology fell more than 8%.

In the afternoon, the innovation drug sector continued to decline, with Yuandong Bio falling more than 8%, Shenlian Bio and Rejing Bio falling more than 6%, Guansheng Tang, Kailaiying, and Lifang Pharmaceuticals falling more than 5%.